BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25875901)

  • 1. 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
    Saito M; Takano T; Nishimura T; Kohara M; Tsukiyama-Kohara K
    PLoS One; 2015; 10(4):e0124197. PubMed ID: 25875901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody 2-152a suppresses hepatitis C virus infection through betaine/GABA transporter-1.
    Satoh M; Saito M; Takano T; Kasama Y; Nishimura T; Nishito Y; Hirata Y; Arai M; Sudoh M; Kai C; Kohara M; Tsukiyama-Kohara K
    J Infect Dis; 2011 Oct; 204(8):1172-80. PubMed ID: 21917889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic polymorphisms in 3β-hydroxysterol Δ24-reductase promoter sequences.
    Salem NE; Saito M; Kasama Y; Ozawa M; Kawabata T; Harada S; Suda H; Asonuma K; El-Gohary A; Tsukiyama-Kohara K
    Microbiol Immunol; 2013 Mar; 57(3):179-84. PubMed ID: 23277918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus promotes expression of the 3β-hydroxysterol δ24-reductase through Sp1.
    Saito M; Kohara M; Tsukiyama-Kohara K
    J Med Virol; 2012 May; 84(5):733-46. PubMed ID: 22431021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxidative stress in hepatocarcinogenesis induced by hepatitis C virus.
    Tsukiyama-Kohara K
    Int J Mol Sci; 2012 Nov; 13(11):15271-8. PubMed ID: 23203124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
    Takano T; Tsukiyama-Kohara K; Hayashi M; Hirata Y; Satoh M; Tokunaga Y; Tateno C; Hayashi Y; Hishima T; Funata N; Sudoh M; Kohara M
    J Hepatol; 2011 Sep; 55(3):512-521. PubMed ID: 21184787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-Induced Oxidative Stress: Battlefield-Winning Strategy.
    Rebbani K; Tsukiyama-Kohara K
    Oxid Med Cell Longev; 2016; 2016():7425628. PubMed ID: 27293514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.
    Wu J; Guo L; Qiu X; Ren Y; Li F; Cui W; Song S
    Br J Cancer; 2020 Nov; 123(11):1673-1685. PubMed ID: 32958824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol Delta24-reductase.
    Nishimura T; Kohara M; Izumi K; Kasama Y; Hirata Y; Huang Y; Shuda M; Mukaidani C; Takano T; Tokunaga Y; Nuriya H; Satoh M; Saito M; Kai C; Tsukiyama-Kohara K
    J Biol Chem; 2009 Dec; 284(52):36442-36452. PubMed ID: 19861417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
    Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
    Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3β-Hydroxysterol-Delta24 reductase plays an important role in long bone growth by protecting chondrocytes from reactive oxygen species.
    Mirza R; Qiao S; Tateyama K; Miyamoto T; Xiuli L; Seo H
    J Bone Miner Metab; 2012 Mar; 30(2):144-53. PubMed ID: 21845517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis.
    Di Stasi D; Vallacchi V; Campi V; Ranzani T; Daniotti M; Chiodini E; Fiorentini S; Greeve I; Prinetti A; Rivoltini L; Pierotti MA; Rodolfo M
    Int J Cancer; 2005 Jun; 115(2):224-30. PubMed ID: 15688385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane topological analysis of 3β-hydroxysteroid-Delta24 reductase (DHCR24) on endoplasmic reticulum.
    Lu X; Li Y; Liu J; Cao X; Wang X; Wang D; Seo H; Gao B
    J Mol Endocrinol; 2012 Feb; 48(1):1-9. PubMed ID: 22010141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.
    Luu W; Zerenturk EJ; Kristiana I; Bucknall MP; Sharpe LJ; Brown AJ
    J Lipid Res; 2014 Mar; 55(3):410-20. PubMed ID: 24363437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus.
    Kuramitsu Y; Harada T; Takashima M; Yokoyama Y; Hidaka I; Iizuka N; Toda T; Fujimoto M; Zhang X; Sakaida I; Okita K; Oka M; Nakamura K
    Electrophoresis; 2006 Apr; 27(8):1651-8. PubMed ID: 16609938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel monoclonal antibody raised against human hepatocellular carcinoma.
    Xie Y; Xie H
    Hybridoma; 1998 Oct; 17(5):437-44. PubMed ID: 9873989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis.
    Lu X; Kambe F; Cao X; Kozaki Y; Kaji T; Ishii T; Seo H
    Endocrinology; 2008 Jul; 149(7):3267-73. PubMed ID: 18339707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC.
    Ke AW; Zhang PF; Shen YH; Gao PT; Dong ZR; Zhang C; Cai JB; Huang XY; Wu C; Zhang L; Kang Q; Liu LX; Xie N; Shen ZZ; Hu MY; Cao Y; Qiu SJ; Sun HC; Zhou J; Fan J; Shi GM
    Oncotarget; 2016 Feb; 7(5):6314-22. PubMed ID: 26756217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.